ZAVZPRET

JSON twin: https://www.healthaidb.com/software/zavzpret.json

Company Name

Pfizer

Product URL

https://www.pfizer.com/products/product-detail/zavzpret

Company URL

https://www.pfizer.com

Categories

• clinical Care
• diagnostic Support
• patient Facing
• Clinical
• Diagnostic

Summary

ZAVZPRET is a nasal spray medication developed by Pfizer for the acute treatment of migraines in adults, providing rapid pain relief within 15 minutes and lasting up to 48 hours.

Description

ZAVZPRET (zavegepant) is a calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray approved by the FDA in March 2023 for the acute treatment of migraines with or without aura in adults. It offers rapid pain relief, with some patients experiencing relief as early as 15 minutes post-administration. The recommended dose is a single 10 mg spray in one nostril, with a maximum of one dose per 24-hour period. Common side effects include taste disorders, nausea, nasal discomfort, and vomiting. Serious side effects may include hypersensitivity reactions, hypertension, and Raynaud's phenomenon. ZAVZPRET is not intended for the preventive treatment of migraines.

Api Available

no

Certifications

• FDA-approved
• Prescription-only medication
• Not for intravenous use
• Not for intramuscular use
• Not for subcutaneous use
• Not for topical use
• Not for ophthalmic use

Company Founding

1849

Company Offices

• United States

Compliance

• FDA-approved
• Prescription-only medication
• Not for intravenous use
• Not for intramuscular use
• Not for subcutaneous use
• Not for topical use
• Not for ophthalmic use

Customers

• Pfizer

Data Residency

US-only

Data Standards

• FDA-approved
• Prescription-only medication
• Not for intravenous use
• Not for intramuscular use
• Not for subcutaneous use
• Not for topical use
• Not for ophthalmic use

Deployment Model

• SaaS

Features

• Acute migraine treatment
• Nasal spray administration
• Rapid pain relief
• Pain freedom within 2 hours
• Pain relief as early as 15 minutes
• Single-dose application
• Non-oral medication option
• FDA-approved
• Indicated for adults with or without aura
• Not for migraine prevention
• Not established for children
• Contains zavegepant
• Calcitonin gene-related peptide (CGRP) receptor antagonist
• Available in the United States
• Prescription-only medication
• Not for intravenous use
• Not for intramuscular use
• Not for subcutaneous use
• Not for topical use
• Not for ophthalmic use

Id

SW2759

Integration Partners

Integrations

Languages Supported

• English

Last Updated

2025-10-11

License

commercial

Market Segment

• enterprise
• consumer

Optional Modules

Os Platforms

• Web

Pricing Details

Pricing information is not publicly available; please contact Pfizer for details.

Pricing Model

contact vendor

Privacy Features

• FDA-approved
• Prescription-only medication
• Not for intravenous use
• Not for intramuscular use
• Not for subcutaneous use
• Not for topical use
• Not for ophthalmic use

Product Code

SW2759

Product Name

ZAVZPRET

Ratings

• 4.4 out of 5 (37 reviews) - G2

Regions Available

• United States

Related Urls

• https://www.zavzpret.com

Release Year

2023

Security Features

• FDA-approved
• Prescription-only medication
• Not for intravenous use
• Not for intramuscular use
• Not for subcutaneous use
• Not for topical use
• Not for ophthalmic use

Specialties

• Neurology
• Pain Management

Support Channels

• email
• phone
• chat
• ticketing
• community
• 24x7

System Requirements

Target Users

• patients
• clinicians

Training Options

• documentation
• webinars
• live_online
• onsite
• certification

Type

product

User Reviews

• As a dad running to soccer games and dance recitals, I always have ZAVZPRET on hand.
• Amid the chaos of my day, it’s vital for me to have fast migraine relief.

Version

1.0

Alternatives

See related products

Canonical JSON

{
  "product_name": "ZAVZPRET",
  "company_name": "Pfizer",
  "product_url": "https://www.pfizer.com/products/product-detail/zavzpret",
  "company_url": "https://www.pfizer.com",
  "related_urls": [
    "https://www.zavzpret.com"
  ],
  "product_code": "SW2759",
  "summary": "ZAVZPRET is a nasal spray medication developed by Pfizer for the acute treatment of migraines in adults, providing rapid pain relief within 15 minutes and lasting up to 48 hours.",
  "description": "ZAVZPRET (zavegepant) is a calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray approved by the FDA in March 2023 for the acute treatment of migraines with or without aura in adults. It offers rapid pain relief, with some patients experiencing relief as early as 15 minutes post-administration. The recommended dose is a single 10 mg spray in one nostril, with a maximum of one dose per 24-hour period. Common side effects include taste disorders, nausea, nasal discomfort, and vomiting. Serious side effects may include hypersensitivity reactions, hypertension, and Raynaud's phenomenon. ZAVZPRET is not intended for the preventive treatment of migraines.",
  "categories": [
    "clinical Care",
    "diagnostic Support",
    "patient Facing",
    "Clinical",
    "Diagnostic",
    "Patient-facing"
  ],
  "market_segment": [
    "enterprise",
    "consumer"
  ],
  "target_users": [
    "patients",
    "clinicians"
  ],
  "specialties": [
    "Neurology",
    "Pain Management"
  ],
  "regions_available": [
    "United States"
  ],
  "languages_supported": [
    "English"
  ],
  "pricing_model": "contact vendor",
  "pricing_details": "Pricing information is not publicly available; please contact Pfizer for details.",
  "license": "commercial",
  "company_offices": [
    "United States"
  ],
  "company_founding": "1849",
  "deployment_model": [
    "SaaS"
  ],
  "os_platforms": [
    "Web"
  ],
  "features": [
    "Acute migraine treatment",
    "Nasal spray administration",
    "Rapid pain relief",
    "Pain freedom within 2 hours",
    "Pain relief as early as 15 minutes",
    "Single-dose application",
    "Non-oral medication option",
    "FDA-approved",
    "Indicated for adults with or without aura",
    "Not for migraine prevention",
    "Not established for children",
    "Contains zavegepant",
    "Calcitonin gene-related peptide (CGRP) receptor antagonist",
    "Available in the United States",
    "Prescription-only medication",
    "Not for intravenous use",
    "Not for intramuscular use",
    "Not for subcutaneous use",
    "Not for topical use",
    "Not for ophthalmic use"
  ],
  "optional_modules": [],
  "integrations": [],
  "data_standards": [
    "FDA-approved",
    "Prescription-only medication",
    "Not for intravenous use",
    "Not for intramuscular use",
    "Not for subcutaneous use",
    "Not for topical use",
    "Not for ophthalmic use"
  ],
  "api_available": "no",
  "system_requirements": "",
  "compliance": [
    "FDA-approved",
    "Prescription-only medication",
    "Not for intravenous use",
    "Not for intramuscular use",
    "Not for subcutaneous use",
    "Not for topical use",
    "Not for ophthalmic use"
  ],
  "certifications": [
    "FDA-approved",
    "Prescription-only medication",
    "Not for intravenous use",
    "Not for intramuscular use",
    "Not for subcutaneous use",
    "Not for topical use",
    "Not for ophthalmic use"
  ],
  "security_features": [
    "FDA-approved",
    "Prescription-only medication",
    "Not for intravenous use",
    "Not for intramuscular use",
    "Not for subcutaneous use",
    "Not for topical use",
    "Not for ophthalmic use"
  ],
  "privacy_features": [
    "FDA-approved",
    "Prescription-only medication",
    "Not for intravenous use",
    "Not for intramuscular use",
    "Not for subcutaneous use",
    "Not for topical use",
    "Not for ophthalmic use"
  ],
  "data_residency": "US-only",
  "customers": [
    "Pfizer"
  ],
  "user_reviews": [
    "As a dad running to soccer games and dance recitals, I always have ZAVZPRET on hand.",
    "Amid the chaos of my day, it’s vital for me to have fast migraine relief."
  ],
  "ratings": [
    "4.4 out of 5 (37 reviews) - G2"
  ],
  "support_channels": [
    "email",
    "phone",
    "chat",
    "ticketing",
    "community",
    "24x7"
  ],
  "training_options": [
    "documentation",
    "webinars",
    "live_online",
    "onsite",
    "certification"
  ],
  "release_year": "2023",
  "integration_partners": [],
  "id": "SW2759",
  "slug": "zavzpret",
  "type": "product",
  "version": "1.0",
  "last_updated": "2025-10-11",
  "links_json": {
    "self": "https://www.healthaidb.com/software/zavzpret.json"
  }
}